As a type one diabetic, I know firsthand how essential access to life-saving medication is—not just for daily comfort, but for survival. Insulin, injections, and continuous glucose monitors (CGMs) are not optional for people with type one diabetes; they are vital tools that keep us healthy and safe. Yet, the prices of these essential resources have risen to levels that put an unfair financial strain on countless diabetics and their families.
Lowering the cost of insulin, injections, and CGM devices would remove this burden, ensuring that no one has to ration supplies or choose between their health and other basic needs. Access to affordable life-saving medication is a fundamental right, not a privilege. With fair pricing, we can enable every diabetic to manage their condition effectively and live without the constant fear of financial hardship.
Passing this policy is not just a step forward in healthcare affordability; it’s a move toward compassion and equity for the millions who depend on these medical essentials. It’s time to make affordable access a reality, so that every diabetic can focus on living a healthy life rather than struggling to afford one.